Indonesian Political, Business & Finance News

BPOM inaugurates pharmacology lab to fortify modernisation of Indonesian jamu

| Source: Antara (Indonesian) Translated from Indonesian | Economy
BPOM inaugurates pharmacology lab to fortify modernisation of Indonesian jamu
Image: Antara (Indonesian)

Jakarta (ANTARA) - The Indonesian Food and Drug Authority (BPOM) has inaugurated and inspected the latest pharmacology laboratory facility owned by PT Sido Muncul in Semarang, representing a tangible synergy between BPOM and industry players in the modernisation of authentic Nusantara jamu.

Speaking in Jakarta on Wednesday, the Head of BPOM, Taruna Ikrar, stated that the urgency of this laboratory becomes increasingly evident when observing the national herbal industry landscape. Currently, over 20,000 jamu products circulate in Indonesia, but only 71 products have successfully transitioned to standardised herbal medicines (OHT), and only 20 products hold the status of registered phytopharmaceuticals with BPOM.

“The main challenge for this industry moving forward is to accelerate the transformation of jamu from being based on empirical evidence (generational experience) to products that are clinically scientifically tested,” he said.

This scientific transformation is also essential to seize the massive global market opportunities for natural medicine products. In 2024, the combined export value of the pharmaceutical and natural medicine industries reached Rp9.9 trillion.

However, he noted that the specific contribution from natural medicine exports has only reached approximately Rp100.8 billion. This gap presents both a significant opportunity and a challenge for all stakeholders to boost the competitiveness of Indonesian herbs in the international market.

Addressing this challenge, BPOM, as the supervisory authority, emphasised its comprehensive role in supporting the progress of the natural ingredients industry. BPOM’s oversight, spanning from pre-market to post-market phases, involves more than just facility inspections and product testing.

He also urged the national natural medicine industry not to cease innovating. The utilisation of modern technology and the strengthening of evidence-based herbal medicine are the primary keys to producing products with genuine efficacy.

With appropriate regulatory guidance, BPOM is optimistic that innovations emerging from domestic laboratories can establish Indonesian jamu as a leader in its own country and a major player in the global market.

BPOM also expressed its appreciation to Sido Muncul for continuously proving its capacity as a pioneer in the international-standard jamu industry. The presence of this laboratory facility is considered crucial, given that Indonesia is a megabiodiversity nation with over 30,000 plant species possessing potential for medicinal, beauty, and premium herbal uses.

“Hopefully, this laboratory can serve as a centre for innovation and a driving force for the birth of globally competitive Indonesian herbal products,” he said.

In the same statement, the President Director of Sido Muncul, Irwan Hidayat, stated that the laboratory is the only facility of its kind owned by a jamu factory. “Our goal in building this is to obtain evidence for our products,” said Irwan.

He also expressed hope that BPOM could provide input so that similar laboratories could be established in various locations, allowing Indonesia’s natural wealth to be utilised rapidly.

More from 10 June 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/bpom-inaugurates-pharmacology-lab-to-fortify-modernisation-of-indonesian-jamu-1781110500)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5603097/bpom-resmikan-lab-farmakologi-kuatkan-modernisasi-jamu-nusantara), translated from Indonesian
Print